MV Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
MV Capital Management's VRTX Position: Q2 2026 in Review
MV Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 18% in Q2 2026, selling an estimated $20.8K and leaving 210 shares worth $104K. The position accounts for 0.01% of the portfolio, ranked #250.
MV Capital Management first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $197K in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- MV Capital Management held 210 shares of Vertex Pharmaceuticals worth $104K as of Q2 2026.
- MV Capital Management sold 47 Vertex Pharmaceuticals shares in Q2 2026, an estimated $20.8K.
- Vertex Pharmaceuticals made up 0.01% of MV Capital Management's portfolio in Q2 2026, its #250 holding.
- MV Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
- MV Capital Management's Vertex Pharmaceuticals position peaked at $197K in Q1 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.